These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7970724

  • 21. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
    Iwai K, Mori N, Oie M, Yamamoto N, Fujii M.
    Virology; 2001 Jan 05; 279(1):38-46. PubMed ID: 11145887
    [Abstract] [Full Text] [Related]

  • 22. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
    Alon Y, Hammerling GJ, Segal S, Bar-Eli M.
    Cancer Res; 1987 May 15; 47(10):2553-7. PubMed ID: 3552201
    [Abstract] [Full Text] [Related]

  • 23. Ras-responsive genes and tumor metastasis.
    Chambers AF, Tuck AB.
    Crit Rev Oncog; 1993 May 15; 4(2):95-114. PubMed ID: 8420573
    [Abstract] [Full Text] [Related]

  • 24. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells.
    Yukimasa N, Isobe K, Nagai H, Takuwa Y, Nakai T.
    Neuropeptides; 1999 Dec 15; 33(6):475-82. PubMed ID: 10657527
    [Abstract] [Full Text] [Related]

  • 25. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells.
    Li J, Johnson TA, Hanson LA, Beer DG.
    Mol Carcinog; 1996 Aug 15; 16(4):213-20. PubMed ID: 8784464
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT, Schneider B, Domann R, Kulesz-Martin M.
    Cancer Res; 1994 Apr 01; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [Abstract] [Full Text] [Related]

  • 28. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells.
    Itoh M, Murata T, Suzuki T, Shindoh M, Nakajima K, Imai K, Yoshida K.
    Oncogene; 2006 Feb 23; 25(8):1195-204. PubMed ID: 16205632
    [Abstract] [Full Text] [Related]

  • 29. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.
    Battista S, de Nigris F, Fedele M, Chiappetta G, Scala S, Vallone D, Pierantoni GM, Mega T, Santoro M, Viglietto G, Verde P, Fusco A.
    Oncogene; 1998 Jul 23; 17(3):377-85. PubMed ID: 9690519
    [Abstract] [Full Text] [Related]

  • 30. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
    Renault MA, Jalvy S, Belloc I, Pasquet S, Sena S, Olive M, Desgranges C, Gadeau AP.
    Circ Res; 2003 Oct 03; 93(7):674-81. PubMed ID: 12970113
    [Abstract] [Full Text] [Related]

  • 31. A short region containing an AP-1 binding site is essential for transforming growth factor-beta-induced c-jun gene expression in osteoblastic cells.
    Hata S, Shimizu T, Fujimoto M.
    IUBMB Life; 2000 Mar 03; 49(3):229-34. PubMed ID: 10868915
    [Abstract] [Full Text] [Related]

  • 32. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D, Hilfiker A, Castellazzi M, Wollert KC, Trautwein C, Schunkert H, Drexler H.
    Cardiovasc Res; 2006 Jul 01; 71(1):108-17. PubMed ID: 16690042
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD, Allen HL, Kraynak AR, Bradley MO.
    Oncogene; 1988 Feb 01; 2(2):141-7. PubMed ID: 3285293
    [Abstract] [Full Text] [Related]

  • 35. c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos.
    Wang ZQ, Liang J, Schellander K, Wagner EF, Grigoriadis AE.
    Cancer Res; 1995 Dec 15; 55(24):6244-51. PubMed ID: 8521421
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR, Tae HJ, Mitin N, Taparowsky EJ.
    Oncogene; 2000 Mar 30; 19(14):1752-63. PubMed ID: 10777209
    [Abstract] [Full Text] [Related]

  • 38. The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site.
    Bost F, Caron L, Vial E, Montreau N, Marchetti I, Dejong V, Defize L, Castellazzi M, Binétruy B.
    Oncogene; 2001 Nov 01; 20(50):7425-9. PubMed ID: 11704873
    [Abstract] [Full Text] [Related]

  • 39. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA, Lianguzova MS, Pospelov VA.
    Tsitologiia; 2004 Nov 01; 46(12):1080-90. PubMed ID: 15747838
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.